Column
-
Forbes India 30 Under 30 2021: A feast of creativity and performance
The 20s is easily the best decade for creativity and imagination; for innovating and starting up. Which is also perhaps the best reason for Forbes India drawing up a list of go-getters and self-starters in their 20s (and younger) every year
-
Accel India: Sharpening investment instincts
Spotting an opportunity early, making follow-on investment rounds, and guiding it to unicorn status is an art few peers would have mastered as well as Accel has
-
Living in hope in 2021
Innovation came back in a year in which a virus ran amok, killing hundreds of thousands. It took a global humanitarian crisis to bring it back. That--and a tribute to Unsung Heroes of 2020 in our latest issue
-
Salvation in a syringe
A decade ago, Zydus Cadila had brought an H1N1 vaccine to market in less than 10 months
-
Their best shots
India will need at least 1.5 billion doses even if just half the population is vaccinated
-
Capital with a conscience
India has a rich tradition of corporate philanthropy, with family foundations of the Tatas, Godrejs, Birlas and Bajajs, among others, doing their bit for nation-building and social welfare. Yet, almost a century later, those efforts aren't proving enough, inadequacies exposed by Covid-19
-
The billionaire fast lane
Two distinct themes emerge from a cursory glance at the rich list: Digital and health
-
In the Crosswinds
Ajay Singh belongs to a rare breed that revels in the Herculean odds of turning around an airline
-
Rushing the big white hope of the antidote
Dr Reddy's Laboratories, risk-taker and pioneer of several new drugs and R&D has its reasons for partnering with Russia, which go way beyond the vaccine.
-
Back as bellwether?
Infosys's performance is a sign of the resilience of its strategy and operating model
